Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of a concurrent multicomponent collection system for the collection and storage of WBC-reduced RBC apheresis concentrates.

Transfusion·2001
Same author

Alpha1-antitrypsin augmentation therapy.

Chest·1997
Same author

Low incidence of red cell and HLA antibody formation by bone marrow transplant patients.

Transfusion·1995
Same author

Autologous and allogeneic red cell survival studies in the presence of autoanti-AnWj.

Transfusion·1993
Same author

Physiological and genetic strategies for enhanced subtilisin production by Bacillus subtilis.

Biotechnology progress·1992
Same author

Family study of alpha 1-antitrypsin deficiency: effects of cigarette smoking, measured genotype, and their interaction on pulmonary function and biochemical traits.

Genetic epidemiology·1992
Same journal

Education Leadership in Accreditation Reform-Reply.

JAMA·2026
Same journal

Complexity of Diagnosing Volume Overload.

JAMA·2026
Same journal

Incorrect Data in Rational Clinical Examination Article.

JAMA·2026
Same journal

Education Leadership in Accreditation Reform.

JAMA·2026
Same journal

Complexity of Diagnosing Volume Overload-Reply.

JAMA·2026
Same journal

Antiviral Therapies for Adults With Mild to Moderate COVID-19 Infection.

JAMA·2026
See all related articles

Related Experiment Video

Updated: Jun 30, 2026

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

Antitrypsin phenotypes in St. Louis.

J A Pierce, B Eradio, T A Dew

    JAMA
    |February 10, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Antitrypsin phenotypes in St. Louis donors showed fewer proteinase inhibitor (Pi) Z alleles than Scandinavian groups. Major antifrypsin variants were less common in Black individuals compared to other participants.

    More Related Videos

    Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
    06:33

    Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

    Published on: June 9, 2018

    In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
    06:41

    In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

    Published on: August 20, 2019

    Related Experiment Videos

    Last Updated: Jun 30, 2026

    A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
    06:49

    A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

    Published on: October 6, 2015

    Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
    06:33

    Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

    Published on: June 9, 2018

    In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
    06:41

    In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

    Published on: August 20, 2019

    Area of Science:

    • Genetics
    • Biochemistry
    • Population Studies

    Background:

    • Alpha-1 antitrypsin (AAT) deficiency is a genetic disorder.
    • Phenotyping AAT is crucial for understanding population-level genetic variations.
    • Previous studies established AAT allele frequencies in European populations.

    Purpose of the Study:

    • To determine alpha-1 antitrypsin (AAT) phenotypes in a St. Louis donor population.
    • To compare AAT allele frequencies with European and Scandinavian populations.
    • To investigate the prevalence of AAT variants in different racial groups.

    Main Methods:

    • Phenotyping of alpha-1 antitrypsin (AAT) was performed.
    • Data collected from 2,285 donors at Barnes Hospital Blood Bank, St. Louis.
    • Allele frequencies were analyzed and compared across demographic groups.

    Main Results:

    • The St. Louis population exhibited fewer proteinase inhibitor (Pi) Z alleles compared to Scandinavian populations.
    • AAT Z allele frequencies in St. Louis were similar to those found in Central Europeans.
    • Major AAT variants were observed 40% less frequently in Black donors than in the overall study group.

    Conclusions:

    • The genetic profile of AAT in St. Louis shows similarities to Central European populations.
    • Significant differences in AAT variant frequencies exist between racial groups within the study.
    • Further research is warranted to explore the implications of these population-specific AAT variations.